Propionic Acidemia clinical trials

Explore recruiting propionic acidemia clinical trials.

Recruiting propionic acidemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Propionic Acidemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

Spain, Netherlands, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Global, Phase 1/2, Open-label, Dose Optimization Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants with Propionic Acidemia

France, Spain, Italy, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Propionic Acidemia trials by city

Propionic Acidemia in Toronto Propionic Acidemia in Vancouver Propionic Acidemia in Montreal Propionic Acidemia in Calgary Propionic Acidemia in Edmonton Propionic Acidemia in Ottawa Propionic Acidemia in Winnipeg Propionic Acidemia in Quebec City Propionic Acidemia in Hamilton Propionic Acidemia in Kitchener Propionic Acidemia in London Propionic Acidemia in Halifax Propionic Acidemia in New York Propionic Acidemia in Los Angeles Propionic Acidemia in Chicago Propionic Acidemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease